Moderna Rest of world — Property, plant and equipment, net decreased by 4.7% to $363.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 4.7%, from $381.00M to $363.00M.
An increase suggests significant capital investment in international infrastructure to support future growth, while a decrease may indicate asset divestment or a shift toward outsourced manufacturing models.
This metric measures the net book value of tangible assets, such as manufacturing facilities, laboratories, and speciali...
Large-cap pharmaceutical companies often disclose regional asset bases to highlight their global manufacturing capacity and supply chain resilience.
mrna_segment_rest_of_world_property_plant_and_equipment_net| Q4 '21 | Q4 '22 | Q4 '23 | Q4 '24 | Q4 '25 | |
|---|---|---|---|---|---|
| Value | $10.00M | $37.00M | $259.00M | $381.00M | $363.00M |
| QoQ Change | — | +270.0% | +600.0% | +47.1% | -4.7% |
| YoY Change | — | +270.0% | +600.0% | +47.1% | -4.7% |